Q2 2022 2Seventy Bio Inc Earnings Call Transcript
Hello and welcome to 2seventy bio's second-quarter 2022 financial results conference call. (Operator Instructions). Please be advised that this call is being recorded. I would now like to turn the call over to Jenn Snyder, head of corporate affairs. You may begin.
Thank you, operator. This morning 2seventy bio issued a press release providing a business update in addition to second-quarter 2022 financial results. The press release can be found in the Investors & Media section of the company's website at 2seventybio.com. On the call today are Nick Leschly, Chief Kairos Officer; Chip Baird, Chief Financial Officer; and Steve Bernstein, Chief Medical Officer.
As a reminder, today's discussion will include forward-looking statements related to 2seventy bio's current plans and expectations which are subject to certain risks and uncertainties. These forward-looking statements include statements regarding our strategic plans, timelines and expectations and statements regarding our financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |